These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Life-threatening agranulocytosis, anemia, and plasmacytosis after dipyrone use for fever in a child. Işık M, Kaya Z, Belen FB, Aktaş AT, Tezer H, Gürsel T. J Pediatr Hematol Oncol; 2014 Jan; 36(1):e46-8. PubMed ID: 23007418 [Abstract] [Full Text] [Related]
24. [The use of metamizole as a risk factor in the occurrence of agranulocytosis]. Vlakhov V, Bakracheva N, Popova L. Vutr Boles; 1988 Jan; 27(2):80-5. PubMed ID: 3046147 [Abstract] [Full Text] [Related]
25. The incidence of dipyrone-induced agranulocytosis in Greece during 1975. Varonos DD, Santamouris S, Karambali S. J Int Med Res; 1979 Jan; 7(6):564-8. PubMed ID: 520659 [Abstract] [Full Text] [Related]
26. Agranulocytosis and near fatal sepsis due to 'Mexican aspirin' (dipyrone). Dorr VJ, Cook J. South Med J; 1996 Jun; 89(6):612-4. PubMed ID: 8638202 [Abstract] [Full Text] [Related]
27. Case Report: Simultaneously Induced Neutropenia and Hemolysis After a Single Metamizole Dose. Allgaier R, Kandulski A, Gülow K, Maier L, Müller M, Tews HC. Drugs R D; 2023 Jun; 23(2):93-98. PubMed ID: 36988798 [Abstract] [Full Text] [Related]
28. Dipyrone and agranulocytosis: what is the risk? Schönhöfer P, Offerhaus L, Herxheimer A. Lancet; 2003 Mar 15; 361(9361):968-9. PubMed ID: 12648993 [No Abstract] [Full Text] [Related]
29. [Clinical otorhinolaryngological symptoms of metamizole-induced agranulocytosis]. Send T, Westermann S, Eichhorn KW, Jakob M. HNO; 2015 Mar 15; 63(3):215-9. PubMed ID: 25515122 [Abstract] [Full Text] [Related]
30. A prospective study of the incidence of agranulocytosis and aplastic anemia associated with the oral use of metamizole sodium in Poland. Maj S, Centkowski P. Med Sci Monit; 2004 Sep 15; 10(9):PI93-5. PubMed ID: 15328493 [Abstract] [Full Text] [Related]
31. Dipyrone and agranulocytosis: what is the risk? Edwards JE, McQuay HJ. Lancet; 2002 Nov 09; 360(9344):1438. PubMed ID: 12433507 [No Abstract] [Full Text] [Related]
32. Metamizole (Dipyrone) as an Alternative Agent in Postoperative Analgesia in Patients with Contraindications for Nonsteroidal Anti-Inflammatory Drugs. Konijnenbelt-Peters J, van der Heijden C, Ekhart C, Bos J, Bruhn J, Kramers C. Pain Pract; 2017 Mar 09; 17(3):402-408. PubMed ID: 27346584 [Abstract] [Full Text] [Related]
33. Advise against metamizole. Neumann J. Dtsch Arztebl Int; 2009 Jan 09; 106(4):55-6; author reply 56. PubMed ID: 19564968 [No Abstract] [Full Text] [Related]
34. [Agranulocytosis after use of metamizole - an underestimated risk?]. Schinz K, Waldfahrer F, Wüst W, Iro H. Laryngorhinootologie; 2020 Oct 09; 99(10):707-712. PubMed ID: 32588405 [Abstract] [Full Text] [Related]
35. Agranulocytosis associated with dipyrone (metamizol). Ibáñez L, Vidal X, Ballarín E, Laporte JR. Eur J Clin Pharmacol; 2005 Jan 09; 60(11):821-9. PubMed ID: 15580488 [Abstract] [Full Text] [Related]
36. Metamizole (Dipyrone) and the Liver: A Review of the Literature. Lutz M. J Clin Pharmacol; 2019 Nov 09; 59(11):1433-1442. PubMed ID: 31433499 [Abstract] [Full Text] [Related]
37. [Fatal Outcome of Agranulocytosis after Re-Exposure to Metamizole and Cefepime-Induced Encephalopathy]. Skaistys A, Rätz Bravo AE, Leuppi-Taegtmeyer A, Zysset Y. Praxis (Bern 1994); 2019 Aug 09; 108(10):693-697. PubMed ID: 31387493 [Abstract] [Full Text] [Related]
38. [Agranulocytosis in a patient treated with metamizole and clopidogrel]. Kummer O, Haschke M, Tuchscherer D, Lampert M, Martius F, Krähenbühl S. Praxis (Bern 1994); 2006 Nov 08; 95(45):1743-5; quiz 1746-7. PubMed ID: 17205929 [No Abstract] [Full Text] [Related]
39. [Treatment of drug-induced agranulocytosis with granulocyte colony stimulating factor (G-CSF) in a surgical intensive care unit]. Huss B, Bogosyan S, Müller E, Götz E. Anasthesiol Intensivmed Notfallmed Schmerzther; 1996 Oct 08; 31(8):529-30. PubMed ID: 9019189 [Abstract] [Full Text] [Related]